MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
出版年份 2019 全文链接
标题
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
作者
关键词
-
出版物
Trials
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-09
DOI
10.1186/s13063-019-3346-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study
- (2018) Oscar Fernández et al. PLoS One
- Bench-to-bedside translation of stem cell therapies: where are we now and where are we going?
- (2016) Gianvito Martino Regenerative Medicine
- Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection
- (2015) Alice Laroni et al. IMMUNOLOGY LETTERS
- Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System
- (2013) Alice Laroni et al. Journal of Neuroimmune Pharmacology
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Mesenchymal stem cells as treatment for MS – progress to date
- (2012) Antonio Uccelli et al. Multiple Sclerosis Journal
- Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models
- (2012) Lianhua Bai et al. NATURE NEUROSCIENCE
- Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study
- (2012) Mandana Mohyeddin Bonab et al. Current Stem Cell Research & Therapy
- Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases
- (2011) Antonio Uccelli et al. LANCET NEUROLOGY
- The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments
- (2011) Peter Connick et al. Trials
- Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
- (2010) Dimitrios Karussis et al. ARCHIVES OF NEUROLOGY
- Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
- (2010) Bassem Yamout et al. JOURNAL OF NEUROIMMUNOLOGY
- The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
- (2010) Mark S Freedman et al. Multiple Sclerosis Journal
- Lesion enhancement diminishes with time in primary progressive multiple sclerosis
- (2010) Z. Khaleeli et al. Multiple Sclerosis Journal
- Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner
- (2009) Moutih Rafei et al. JOURNAL OF IMMUNOLOGY
- Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune Encephalomyelitis
- (2009) Gabriela Constantin et al. STEM CELLS
- Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune Encephalomyelitis
- (2008) Ibrahim Kassis et al. ARCHIVES OF NEUROLOGY
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started